Статья

Longitudinal high-throughput TCR repertoire profiling reveals the dynamics of T-cell memory formation after mild COVID-19 infection.

A. A. Minervina, E. A. Komech, A. Titov, K. M. Bensouda, E. Rosati, I. Z. Mamedov, A. Franke, G. A. Efimov, D. M. Chudakov, T. Mora, A. M. Walczak, Y. B. Lebedev, M. V. Pogorelyy,
2021

COVID-19 is a global pandemic caused by the SARS-CoV-2 coronavirus. T cells play a key role in the adaptive antiviral immune response by killing infected cells and facilitating the selection of virus-specific antibodies. However, neither the dynamics and cross-reactivity of the SARS-CoV-2-specific T-cell response nor the diversity of resulting immune memory is well understood. In this study, we use longitudinal high-throughput T-cell receptor (TCR) sequencing to track changes in the T-cell repertoire following two mild cases of COVID-19. In both donors, we identified CD4(+) and CD8(+) T-cell clones with transient clonal expansion after infection. We describe characteristic motifs in TCR sequences of COVID-19-reactive clones and show preferential occurrence of these motifs in publicly available large dataset of repertoires from COVID-19 patients. We show that in both donors, the majority of infection-reactive clonotypes acquire memory phenotypes. Certain T-cell clones were detected in the memory fraction at the pre-infection time point, suggesting participation of pre-existing cross-reactive memory T cells in the immune response to SARS-CoV-2.

Цитирование

Похожие публикации

Документы

Источник

Версии

  • 1. Version of Record от 2021-07-23

Метаданные

Об авторах
  • A. A. Minervina
    Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Moscow, Russian Federation
  • E. A. Komech
    Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Moscow, Russian Federation.
  • A. Titov
    National Research Center for Hematology, Moscow, Russian Federation.
  • K. M. Bensouda
    Laboratoire de physique de l'École Normale Supérieure, ENS, PSL, Sorbonne Universite, Universite de Paris, and CNRS, Paris, France.
  • E. Rosati
    Institute of Clinical Molecular Biology, Kiel University, Kiel, Germany.
  • I. Z. Mamedov
    Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Moscow, Russian Federation; Pirogov Russian National Research Medical University, Moscow, Russian Federation; Masaryk University, Central European Institute of Technology, Brno, Czech Republic; V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology, Moscow, Russian Federation.
  • A. Franke
    Institute of Clinical Molecular Biology, Kiel University, Kiel, Germany.
  • G. A. Efimov
    National Research Center for Hematology, Moscow, Russian Federation.
  • D. M. Chudakov
    Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Moscow, Russian Federation; Pirogov Russian National Research Medical University, Moscow, Russian Federation; Masaryk University, Central European Institute of Technology, Brno, Czech Republic.
  • T. Mora
    Laboratoire de physique de l'École Normale Supérieure, ENS, PSL, Sorbonne Universite, Universite de Paris, and CNRS, Paris, France.
  • A. M. Walczak
    Laboratoire de physique de l'École Normale Supérieure, ENS, PSL, Sorbonne Universite, Universite de Paris, and CNRS, Paris, France.
  • Y. B. Lebedev
    Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Moscow, Russian Federation; Moscow State University, Moscow, Russian Federation.
  • M. V. Pogorelyy
    Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Moscow, Russian Federation; Pirogov Russian National Research Medical University, Moscow, Russian Federation.
Предметная рубрика
  • COVID-19; RepSeq; SARS-CoV-2; TCR
Название журнала
  • eLife
Том
  • 10
Тип документа
  • journal article
Версия
  • AO
Тип лицензии Creative Commons
  • CC BY
Правовой статус документа
  • Свободная лицензия
Источник
  • wos